Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARD | Q03181 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | LAP3 | P28838 | 4/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | METAP1 | P53582 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | ANPEP | P15144 | 3/20 | 0.34 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1666156 | 0.87 | PPARD (0.54) | PPARDTSHRTDP1TP53 | |
| Chloromethane SCHEMBL27804708 | 0.84 | PPARD (0.56) | PPARDTSHRTDP1TP53CYP3A4 | |
| SCHEMBL1661755 | 0.84 | — | — | |
| Hydrochloric Acid SCHEMBL3955404 | 0.82 | PPARD (0.58) | PPARDTSHRTDP1TP53 | |
| Hydrochloric Acid SCHEMBL3549676 | 0.82 | — | — | |
| SCHEMBL27932756 | 0.82 | — | — | |
| Phosphoric Acid SCHEMBL8602797 | 0.82 | PPARD (0.58) | PPARDTSHRTDP1TP53 | |
| SCHEMBL13836319 | 0.82 | — | — | |
| Ethane SCHEMBL27795868 | 0.82 | PPARD (0.58) | PPARDTSHRTDP1TP53 | |
| SCHEMBL371462 | 0.77 | GABBR2 (0.48) | PPARDTSHRCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1703553-A | Cationised polysaccharide product | AKZO NOBEL NV (NL) | 2005-11-30 | — | — | CN | disclosed |
| EP-1546455-A1 | CATIONISED POLYSACCHARIDE PRODUCT | Akzo Nobel N.V. (NL) | 2005-06-29 | — | — | EP | disclosed |
| US-20040138438-A1 | Cationised polysaccharide product | AKZO NOBEL N.V. (NL) | 2004-07-15 | — | — | US | disclosed |
| US-20040104004-A1 | Cationised polysaccharide product | AKZO NOBEL N.V. (NL) | 2004-06-03 | — | — | US | disclosed |
| WO-2004031478-A1 | CATIONISED POLYSACCHARIDE PRODUCT | AKZO NOBEL N.V. (NL) | 2004-04-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040138438-A1 | Cationised polysaccharide product | CHIA, CHIT1, ALG1 | PPARD 4376/4885TSHR 4416/4885TDP1 1025/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.